|
ZFP90 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.115800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.333400E-01 |
| Normal-vs-Stage2 |
5.477800E-03 |
| Normal-vs-Stage3 |
1.77268999999036E-05 |
| Normal-vs-Stage4 |
2.22459999998925E-06 |
| Stage1-vs-Stage2 |
2.032000E-02 |
| Stage1-vs-Stage3 |
1.52137999999136E-05 |
| Stage1-vs-Stage4 |
1.17460000004233E-06 |
| Stage2-vs-Stage3 |
5.131600E-01 |
| Stage2-vs-Stage4 |
3.173800E-01 |
| Stage3-vs-Stage4 |
5.804600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.964300E-03 |
| Normal-vs-AfricanAmerican |
2.590300E-02 |
| Normal-vs-Asian |
5.200000E-01 |
| Caucasian-vs-AfricanAmerican |
7.439200E-01 |
| Caucasian-vs-Asian |
9.674100E-02 |
| AfricanAmerican-vs-Asian |
1.275770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.061100E-03 |
| Normal-vs-Female |
1.009820E-02 |
| Male-vs-Female |
6.714600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.803990E-01 |
| Normal-vs-Age(41-60Yrs) |
7.390100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.983400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.061100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.592600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.823600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.250800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.160100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.933900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.679600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.137800E-01 |
| Normal-vs-Grade 2 |
2.559600E-01 |
| Normal-vs-Grade 3 |
4.562400E-04 |
| Normal-vs-Grade 4 |
3.12350000308825E-08 |
| Grade 1-vs-Grade 2 |
9.077800E-02 |
| Grade 1-vs-Grade 3 |
1.561330E-03 |
| Grade 1-vs-Grade 4 |
1.72809999998691E-06 |
| Grade 2-vs-Grade 3 |
4.101200E-03 |
| Grade 2-vs-Grade 4 |
3.44060000490032E-08 |
| Grade 3-vs-Grade 4 |
1.376530E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.838800E-01 |
| Normal-vs-ccB subtype |
4.001900E-03 |
| ccA subtype-vs-ccB subtype |
5.161600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.820500E-03 |
| Normal-vs-N1 |
1.640350E-02 |
| N0-vs-N1 |
2.760200E-01 |
|
|
